Welcome to the OncoSil Medical Ltd investor centre.
OncoSil Medical Ltd is a publicly traded biotechnology company on the Australian stock exchange (ASX: OSL).
At OncoSil Medical we have a policy of continuous disclosure. We keep shareholders informed through ASX announcements, the company website, regular newsletters and our annual report. We encourage our shareholders to attend and participate at our annual general meetings.
OncoSil Medical Investor Relations
Contact OncoSil Medical Investor Relations to ask a question relating to an investment in OncoSil Medical.
OncoSil 2022 Annual Report
ASX announcements & reports
Read the latest ASX announcements
We have a continuous commitment to quality at OncoSil Medical.
Please see our Quality Policy here.